Your email has been successfully added to our mailing list.

×
0.00112198260926943 0.0015344762156186 0.00237596317257071 -0.00341544706057066 -0.0157902552510437 -0.0102628409259658 -0.0182652168891383 -0.0182652168891383
Stock impact report

Why Progenics Pharmaceuticals, Inc.'s Shareholders Came to Their Senses [The Motley Fool]

PROGENICS PHARMACEUTICALS (PGNX) 
Last progenics pharmaceuticals earnings: 8/9 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: progenics.com
Company Research Source: The Motley Fool
The biotech progresses, but it should have been expected. Brian Orelli ( TMFBiologyFool ) Dec 29, 2017 at 1:21PM What happened Progenics Pharmaceuticals ( NASDAQ:PGNX ) was up as much as 23% this morning after announcing that the FDA accepted the marketing application for its cancer drug Azedra. Investors have since come to their senses, with shares trading up 4.2% at 12:09 p.m. EST. Image source: Getty Images. So what The FDA does a cursory review when it accepts the application and can refuse to file the application if it doesn't meet the agency's standards; getting a refuse to file ruling would typically send shares down, but meeting the low bar of getting the application accepted doesn't justify a double-digit increase. That goes double for Progenics since the FDA had already signed off on the clinical trial design under a Special Show less Read more
Impact Snapshot
Event Time:
PGNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for PGNX alerts
Opt-in for
PGNX alerts

from News Quantified
Opt-in for
PGNX alerts

from News Quantified